Evidence map›Paper›PMID 33294749›Full record

ArticleInfectious Disease Modelling2021

Modeling and forecasting of COVID-19 using a hybrid dynamic model based on SEIRD with ARIMA corrections.

Maher Ala'raj, Munir Majdalawieh, Nishara Nizamuddin

Abstract read
In one paragraph

Article in Infectious Disease Modelling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. COVID-19 Patterns in Araraquara, Brazil: A Multimodal Analysis.International journal of environmental research and public health · 2023
    Article
  12. Machine Learning and COVID-19: Lessons from SARS-CoV-2.Advances in experimental medicine and biology · 2023
    Article
  13. Article
  14. Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy.The European journal of health economics : HEPAC : health economics in prevention and care · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Forecasting COVID-19 Case Trends Using SARIMA Models during the Third Wave of COVID-19 in Malaysia.International journal of environmental research and public health · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maher Ala'rajDepartment of Information Systems, College of Technological Innovation, Zayed University, Dubai, 19282, United Arab Emirates.
Munir MajdalawiehDepartment of Information Systems, College of Technological Innovation, Zayed University, Dubai, 19282, United Arab Emirates.
Nishara NizamuddinDepartment of Information Systems, College of Technological Innovation, Zayed University, Dubai, 19282, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of novel coronavirus (COVID-19) attracted worldwide attention. It has posed a significant challenge for the global economies, especially the healthcare sector. Even with a robust healthcare system, countries were not prepared for the ramifications of COVID-19. Several statistical, dynamic, and mathematical models of the COVID-19 outbreak including the SEIR model have been developed to analyze the infection its transmission dynamics. The objective of this research is to use public data to study the properties associated with the COVID-19 pandemic to develop a dynamic hybrid model based on SEIRD and ascertainment rate with automatically selected parameters. The proposed model consists of two parts: the modified SEIRD dynamic model and ARIMA models. We fit SEIRD model parameters against historical values of infected, recovered and deceased population divided by ascertainment rate, which, in turn, is also a parameter of the model. Residuals of the first model for infected, recovered, and deceased populations are then corrected using ARIMA models. The model can analyze the input data in real-time and provide long- and short-term forecasts with confidence intervals. The model was tested and validated on the US COVID statistics dataset from the COVID Tracking Project. For validation, we use unseen recent statistical data. We use five common measures to estimate model prediction ability: MAE, MSE, MLSE, Normalized MAE, and Normalized MSE. We proved a great model ability to make accurate predictions of infected, recovered, and deceased patients. The output of the model can be used by the government, private sectors, and policymakers to reduce health and economic risks significantly improved consumer credit scoring.

Indexed as

ARIMACoronavirusCOVID 19Hybrid modelSEIRD model

Identifiers

PMID33294749
PMCPMC7713640

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.